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http://dx.doi.org/10.1016/j.cmet.2014.02.016Gerlic et al. contacted us a few months
ago regarding the concerns expressed in
the accompanying letter. We have
communicated with them about their
observations relative to conclusions from
our original paper (Im et al., 2011) and
for the field moving forward. Based
on their data, we performed a sepa-
rate DNA sequence analysis of the
Nlrp1a locus in our SREBP-1a-deficient
(SREBP-1aDF) mice and confirmed that
it is derived from the 129 strain. However,
the issues raised by this observation are
almost certainly more complicated than
the tight linkage between the Srebf1 and
Nlrp1a loci and the extent of backcross-
ing. In fact, similar complications could
affect observations regarding Nlrp1a
function from another recent report from
Gerlic and colleagues (Masters et al.,
2012). In this study, the Nlrp1a locus
from the C57BL/6 strain, a line where
Nlrp1a and Nlrp1c are expressed in
bone marrow-derived macrophages
(BMDMs), was inserted into the BALB/c
strain where Nlrp1a/Nlrp1c also appear
to be silent in BMDMs (similar to the 129
strain).
In addition to this study, there are
numerous publications that suggest that
strain differences at the murine Nrlp1
locus significantly influence responses
to pathogens and inflammatory stimuli.However, a major relevant issue that
has not been solved is why the Nlrp1a lo-
cus in the 129 strain, and several others,
including BALB/c, seems to be silenced
at least in BMDMs cultured in vitro.
To begin to address this issue, we
compared the Nlrp1a DNA sequence
and putative mRNA coding regions from
the C57BL/6 and 129 strains (Figure S1).
The alignment predicts almost complete
identity at the protein level between the
two strains, with the exception of only
two amino acid differences, both of
which correspond to residues that
display variations between different
mouse strains (Sastalla et al., 2013).
Interestingly, the Nlrp1a 50-flanking
sequences from the two strains are
even more highly conserved. The exten-
sive conservation strongly suggests that
the Nlrp1a coding sequence is intact in
both strains and that major structural
alterations surrounding the Nlrp1a gene
are an unlikely explanation for the
absence of Nlrp1a expression in 129
BMDM. This is important because it
suggests the Nlrp1a locus is under evolu-
tionary pressure to maintain the coding
integrity and thus predicts that it is
expressed under the appropriate circum-
stances in 129 mice, we would argue in
response to SREBP-1a activation. Also,
it should be noted that the absenceof 129-derived Nlrp1a transcripts in
cultured macrophages is not reflective
of Nlrp1a expression in an in vivo context
where the SREBP-1aDF mice exhibit a
profound inflammatory phenotype (Im
et al., 2011).
The data in Figures 5 and 6 of our orig-
inal paper demonstrate that Nlrp1a is
directly activated by SREBP-1a because
reintroduction of SREBP-1a into the
SREBP-1aDF macrophages through
either adenovirus vector delivery or
plasmid transfection activates Nlrp1a
mRNA expression and restores LPS-
dependent IL-1b secretion to wild-type
levels (Im et al., 2011). We recently
repeated the activation experiment with
identical results. These observations
demonstrate that the Nlrp1a locus in the
SREBP-1aDF strain can be expressed in
isolated macrophages when SREBP-1a
is reintroduced. Why Nlrp1a is not ex-
pressed in 129 BMDMs as well as from
several other strains is an intriguing issue,
one that deserves more investigation.
Similarly, why further backcrossing to
the C57BL/6 strain (which would alter
many loci on chromosome 11 and else-
where throughout the genome) would
restore Nlrp1a expression deserves
more study as well.
With regard to a second issue, IL-1b
secretion, data in our original paper
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Lettersshowed that the SREBP-1aDF macro-
phages secreted reduced levels of IL-1b
following LPS challenge relative to wild-
type control mice (Im et al., 2011). This
defect was not observed by Gerlic et al.
We cannot explain this inconsistency,
but it could relate to differences in the
basal inflammatory state of the mice/
macrophages in different mouse facilities.
The defect in IL-1b secretion observed
from the SREBP-1aDF macrophages
was reproduced in two different labora-
tories that contributed to the original
study and in response to both LPS and
Salmonella Typhimurium challenge.
These results were consistent over thecourse of several years as our project
developed. In addition, our results with
cultured macrophages are also consis-
tent with our in vivo experiments where
the SREBP-1aDF mice challenged either
with LPS or subjected to cecal ligation
and puncture (CLP) had reduced serum
levels of IL-1b. Additionally, using siRNA
knockdown, we also showed that Nlrp1a
and Nlrp3 both contribute to stimulation
of maximal IL-1b secretion following LPS
challenge in C57BL/6 macrophages.
Importantly, these responses are also
consistent with results from the Nlrp3
and Asc knockout mice as discussed in
our original paper (Im et al., 2011).Cell MetabolismSUPPLEMENTAL INFORMATION
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